A Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of TIX100 in Healthy Subjects (NCT06800729)

🧪 Interventions in This Study

• TIX100, an orally available inhibitor of thioredoxin-interacting protein (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• ProSciento, Inc. — Chula Vista, California

📞 Contact the Study Coordinator

Phone: (619) 427-1300

Email: hello@myproscientostudy.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Healthy

• Xanthohumol Metabolism and Signature — Portland, Oregon
• Examining the Effects of Regular Brief Internet-based Meditation Practice on Mental Health and Well Being — Stanford, California
• A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions — Detroit, Michigan
• A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004) — Hollywood, Florida
• Pediatric Parenting Support in Flint — Flint, Michigan
• Biomarker-estimated Flavanol Intake in Davis (FID) — Davis, California

Explore by condition: All Healthy clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.